While safeguarding both patients and the healthcare team from unnecessary risk of SARS-CoV-2, telehealth technology and its widespread adoption among healthcare practitioners and patients have allowed for innovative patient care strategies. Virtual education has also persevered and improved during this year of in-person and travel adversity. Scientific meetings are critical for the ongoing education of physicians, nurses, and all allied health care personnel. In this issue’s Spotlight section, we showcase advancements in urologic oncology presented at the International Bladder Cancer Network (IBCN) Virtual Annual Meeting and the Société Internationale d’Urologie (SIU) 2020 Virtual Annual Congress. We also highlight telemedicine sessions, which have become an integral part of cancer care delivery during the Covid-19 pandemic.
There have been many important systemic therapy advances in treatment for patients with renal cell carcinomas (both clear call and nonclear cell). This issue’s cover story expertly reviews the transformational change of therapeutic options for renal cell carcinomas during the past fifteen years. Most recently, combining immunotherapy-based approaches has both potentials for long-term cure or otherwise significantly delaying disease progression.
Importantly, and not until recently, there has been a paucity of well-performed trials to delineate the optimal timing of radiotherapy for high-risk post radical prostatectomy patients, specifically addressing adjuvant timing versus salvage radiation therapy. In the Expert Perspective article, we highlight data derived from phase 3 trials: RADICALS-RT, GETUC-AFU 17, RAVES, and the ARTISTIC prospective systematic review and meta-analysis, as the data and trials review, will guide and assist clinicians in their patient discussion for this controversial decision, i.e., immediate adjuvant radiation therapy (RT) vs. early salvage RT post RP.
In closing, the continued progress in the field of genitourinary malignancies and our global healthcare community’s dedicated efforts have been silver linings of a dystopian 2020. Social cohesion, change, and resilience are evolving. As we look ahead to 2021, we wish you, your loved ones, as well as all of your friends and neighbors, continued health, wellness, and peace.
Neal Shore, MD, FACS
The Evolving Landscape of First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
Post-Operative Radiotherapy in Prostate Cancer – The State of the Data
Download: Everyday Urology — Oncology Insights, Volume 5 Issue 4